The Encephalitis Podcast Ep 48 - Clinical Trials with Stacey Clardy cover art

The Encephalitis Podcast Ep 48 - Clinical Trials with Stacey Clardy

The Encephalitis Podcast Ep 48 - Clinical Trials with Stacey Clardy

Listen for free

View show details

About this listen

In this episode, Prav - Senior Medical Writer for Encephalitis International - talks to Dr Stacy Clardy about clinical trials to to find out more about this important aspect of developing treatments for encephalitis. Doctor Clardy is both clinical and research faculty in the Division of Neuroimmunology and Autoimmune Neurology within the Department of Neurology at the University of Utah and the Salt Lake City Veterans Affairs Hospital. Her clinical specialisation and research focus is in the field of autoimmune neurology. Dr Clardy is the Principal Investigator, PI of the ExTINGUISH trial, a randomised clinical trial for NMDA receptor encephalitis at 37 sites, including two European sites, with enrolment having begun in early 2022.

If you have been affected by encephalitis and are in need of some support, please visit https://www.encephalitis.info/support

If you would like to stay up to date with our news and events please sign up to our mailing list here: https://www.encephalitis.info/keep-in-touch

Support our work providing help and assistance to families affected by encephalitis by visiting: https://www.encephalitis.info/donate

Follow Encephalitis International:

Facebook: https://www.facebook.com/encephalitisinternational

LinkedIn: https://www.linkedin.com/company/encephalitisinternational

Instagram: https://www.instagram.com/encephalitisinternational

What listeners say about The Encephalitis Podcast Ep 48 - Clinical Trials with Stacey Clardy

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.